Hasta la próxima

Auto reproducción

Managing Avelumab Side Effects in Patients With Merkel Cell Carcinoma

2 vistas • 07/17/23
Compartir
Empotrar
administrator
administrator
Suscriptores
0

Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses the adverse event profile of avelumab (Bavencio) for patients with Merkel cell carcinoma.

Mostrar más
0 Comentarios sort Ordenar por
Comentarios de Facebook

Hasta la próxima

Auto reproducción